ATE284714T1 - Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren - Google Patents
Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahrenInfo
- Publication number
- ATE284714T1 ATE284714T1 AT97909451T AT97909451T ATE284714T1 AT E284714 T1 ATE284714 T1 AT E284714T1 AT 97909451 T AT97909451 T AT 97909451T AT 97909451 T AT97909451 T AT 97909451T AT E284714 T1 ATE284714 T1 AT E284714T1
- Authority
- AT
- Austria
- Prior art keywords
- production method
- suitable conjugation
- plate substitute
- substitute
- plate
- Prior art date
Links
- 230000021615 conjugation Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6927—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9621886.2A GB9621886D0 (en) | 1996-10-21 | 1996-10-21 | Microparticles and their therapeutic use |
| GBGB9702652.0A GB9702652D0 (en) | 1997-02-10 | 1997-02-10 | Conjugates and their preparation |
| PCT/GB1997/002877 WO1998017319A2 (en) | 1996-10-21 | 1997-10-17 | Platelet substitutes and conjugation methods suitable for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE284714T1 true ATE284714T1 (de) | 2005-01-15 |
Family
ID=26310263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97909451T ATE284714T1 (de) | 1996-10-21 | 1997-10-17 | Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5977313A (enExample) |
| EP (1) | EP1028752B1 (enExample) |
| JP (1) | JP2001504813A (enExample) |
| AR (1) | AR008680A1 (enExample) |
| AT (1) | ATE284714T1 (enExample) |
| AU (1) | AU718956B2 (enExample) |
| CA (1) | CA2269335C (enExample) |
| DE (1) | DE69731985T2 (enExample) |
| ES (1) | ES2232862T3 (enExample) |
| WO (1) | WO1998017319A2 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391343B1 (en) | 1991-01-15 | 2002-05-21 | Hemosphere, Inc. | Fibrinogen-coated particles for therapeutic use |
| CA2294494A1 (en) | 1997-06-05 | 1998-12-10 | Richard C. K. Yen | Fibrinogen-coated microspheres |
| GB9724143D0 (en) * | 1997-11-14 | 1998-01-14 | Andaris Ltd | Pharmaceutical conjugate |
| JP2003524437A (ja) * | 1998-02-20 | 2003-08-19 | エラン・ドラッグ・デリバリー・リミテッド | 治療に用いるためのフィブリノーゲンを含んでなる生成物 |
| GB9825105D0 (en) * | 1998-11-16 | 1999-01-13 | Andaris Ltd | Pharamaceutical conjugates |
| GB9827813D0 (en) * | 1998-12-17 | 1999-02-10 | Andaris Ltd | Pharmaceutical conjugates |
| DE19926475A1 (de) * | 1999-06-10 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Träger-Pharmaka-Konjugate |
| US20040126900A1 (en) * | 2001-04-13 | 2004-07-01 | Barry Stephen E | High affinity peptide- containing nanoparticles |
| DE10135356C1 (de) * | 2001-07-20 | 2003-04-17 | Schering Ag | Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen |
| US7906102B2 (en) | 2001-10-03 | 2011-03-15 | Vanderbilt University | Ligands to radiation-induced molecules |
| US7306925B2 (en) * | 2001-11-09 | 2007-12-11 | Vanderbilt University | Phage antibodies to radiation-inducible neoantigens |
| WO2003028640A2 (en) * | 2001-10-03 | 2003-04-10 | Vanderbilt University | In vivo panning for ligands to radiation-induced molecules |
| GB0323378D0 (en) * | 2003-10-07 | 2003-11-05 | Univ Leicester | Therapeutic agent |
| GB0516091D0 (en) * | 2005-08-04 | 2005-09-14 | Haemostatix Ltd | Therapeutic agent |
| US20080015145A1 (en) * | 2006-07-11 | 2008-01-17 | Maria Gyongyossy-Issa | Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
| JP5997443B2 (ja) | 2008-05-16 | 2016-09-28 | バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅ ＬＬＣ | 標的化凝固因子およびそれを使用する方法 |
| CA2761903C (en) | 2009-05-28 | 2018-04-10 | Profibrix B.V. | Dry powder fibrin sealant |
| GB201101740D0 (en) | 2011-02-01 | 2011-03-16 | Haemostatix Ltd | Therapeutic agents with improved fibrinogen binding |
| WO2013019730A1 (en) | 2011-07-29 | 2013-02-07 | The Washington University | Antibodies to tip-1 and grp78 |
| GB201201751D0 (en) | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
| US20130202656A1 (en) | 2012-02-03 | 2013-08-08 | Dynasil Biomedical Corporation | Systems and kits for the fabrication of tissue patches |
| GB201204868D0 (en) | 2012-03-20 | 2012-05-02 | San Raffaele Centro Fond | Peptides |
| EP3172222A4 (en) | 2014-07-24 | 2018-03-21 | Washington University | Compositions targeting radiation-induced molecules and methods of use thereof |
| US9540548B1 (en) | 2015-08-07 | 2017-01-10 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
| US9833538B2 (en) | 2015-08-07 | 2017-12-05 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
| CA2994959A1 (en) | 2015-08-07 | 2017-02-16 | Xcede Technologies, Inc. | Adhesive compositions and related methods |
| CN107686507B (zh) * | 2016-08-05 | 2021-02-12 | 首都医科大学 | Rgds-阿霉素,其合成,活性和应用 |
| CN107686508B (zh) * | 2016-08-05 | 2021-02-12 | 首都医科大学 | 阿霉素-rgds,其合成,活性和应用 |
| US11352436B2 (en) | 2017-02-10 | 2022-06-07 | Washington University | Antibodies to TIP1 and methods of use thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8334499D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Derivatives |
| GB8400653D0 (en) * | 1984-01-11 | 1984-02-15 | Beecham Group Plc | Conjugates |
| US4666884A (en) * | 1984-04-10 | 1987-05-19 | New England Deaconess Hospital | Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls |
| US4661471A (en) * | 1984-04-10 | 1987-04-28 | New England Deaconess Hospital | Method of inhibiting and inducing human platelet aggregation |
| US5069936A (en) * | 1987-06-25 | 1991-12-03 | Yen Richard C K | Manufacturing protein microspheres |
| AU3149289A (en) * | 1988-03-18 | 1989-09-21 | Rockefeller University, The | Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor |
| WO1990003401A1 (en) * | 1988-09-30 | 1990-04-05 | Neorx Corporation | Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages |
| DK0494417T3 (da) * | 1991-01-10 | 1996-05-13 | Basf Corp | Fremgangsmåde til tværbinding af gelatine og til inkorporering af et materiale deri |
| US5725804A (en) * | 1991-01-15 | 1998-03-10 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
| US5616311A (en) * | 1991-01-15 | 1997-04-01 | Hemosphere, Inc. | Non-crosslinked protein particles for therapeutic and diagnostic use |
| ATE147976T1 (de) * | 1991-01-15 | 1997-02-15 | Hemosphere Inc | Protein nanomatrizen und verfahren zur herstellung |
| WO1992013547A1 (en) * | 1991-02-07 | 1992-08-20 | Alexander Mellon Eaton | Drug delivery composition and method of using the same |
| AU1461592A (en) * | 1991-02-07 | 1992-09-07 | Fibratek, Inc. | Fibrinogen based adhesive |
| GB9107628D0 (en) * | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
| EP0673384A4 (en) * | 1992-12-10 | 1996-10-09 | Univ Minnesota | POLYPEPTIDES USEFUL IN TREATING INFLAMMABLE DISEASES. |
| GB9423419D0 (en) * | 1994-11-19 | 1995-01-11 | Andaris Ltd | Preparation of hollow microcapsules |
| JP4350165B2 (ja) * | 1994-12-16 | 2009-10-21 | クアドラント、 ドラッグ、 デリバリー、 リミテッド | 架橋した微細粒子、及びそれら粒子の治療薬用ビヒクルとしての使用 |
| EP0727225A3 (en) * | 1995-02-14 | 1997-01-15 | Sonus Pharma Inc | Compositions and methods for directed ultrasonic imaging |
| AU6100296A (en) * | 1995-06-06 | 1996-12-24 | Hemosphere, Inc. | Protein particles for therapeutic and diagnostic use |
-
1997
- 1997-10-17 JP JP51910098A patent/JP2001504813A/ja active Pending
- 1997-10-17 CA CA2269335A patent/CA2269335C/en not_active Expired - Fee Related
- 1997-10-17 DE DE69731985T patent/DE69731985T2/de not_active Expired - Lifetime
- 1997-10-17 ES ES97909451T patent/ES2232862T3/es not_active Expired - Lifetime
- 1997-10-17 AT AT97909451T patent/ATE284714T1/de active
- 1997-10-17 AU AU47135/97A patent/AU718956B2/en not_active Ceased
- 1997-10-17 EP EP97909451A patent/EP1028752B1/en not_active Expired - Lifetime
- 1997-10-17 US US08/953,514 patent/US5977313A/en not_active Expired - Lifetime
- 1997-10-17 WO PCT/GB1997/002877 patent/WO1998017319A2/en not_active Ceased
- 1997-10-20 AR ARP970104847A patent/AR008680A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998017319A3 (en) | 1998-06-11 |
| EP1028752A2 (en) | 2000-08-23 |
| ES2232862T3 (es) | 2005-06-01 |
| JP2001504813A (ja) | 2001-04-10 |
| WO1998017319A2 (en) | 1998-04-30 |
| DE69731985T2 (de) | 2005-12-29 |
| CA2269335C (en) | 2010-05-25 |
| CA2269335A1 (en) | 1998-04-30 |
| AR008680A1 (es) | 2000-02-09 |
| US5977313A (en) | 1999-11-02 |
| AU718956B2 (en) | 2000-05-04 |
| DE69731985D1 (de) | 2005-01-20 |
| AU4713597A (en) | 1998-05-15 |
| EP1028752B1 (en) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE284714T1 (de) | Plättchen-ersatzmittel und geeignetes konjugations-herstellungsverfahren | |
| DE69714852D1 (de) | Stichfestes kleidungsstück und herstellungsverfahren dafür | |
| DE69531617D1 (de) | Polymere mikrokugen und herstellungsverfahren | |
| DK0796846T3 (da) | 2-Aryl-substituerede pyridiner | |
| DK0874733T3 (da) | Syntetisk laminatstruktur og fremgangsmåde til fremstilling deraf | |
| BR9708989A (pt) | Piridil cetoenóis substituídos | |
| DE69920376D1 (de) | Anschluss und Anpressverfahren | |
| DE69529171D1 (de) | Kunstmarmor und herstellungsverfahren dafür | |
| DE69702340D1 (de) | Resonanzetikett und dessen herstellungsverfahren | |
| IS8717A (is) | Ísókínólín og framleiðsla þeirra | |
| DE69808499D1 (de) | Widerstand und herstellungsverfahren | |
| DE69720774D1 (de) | S-omeprazol in festform | |
| NO992297L (no) | FremgangsmÕte og nye forbindelser | |
| DE69714458D1 (de) | Geprägte warenbahn | |
| NO984031D0 (no) | Bµreelement og fremgangsmÕte for fremstilling av samme | |
| DE69736827D1 (de) | Sperrschnitt-feldeffektreferenzpotentiale und herstellungsverfahren dazu | |
| FI963905L (fi) | Hyytelöintituote | |
| DE69716556D1 (de) | Längsgestreckter Vliesstoff und dessen Herstellungsverfahren | |
| DE69607757D1 (de) | Poröse materialbahn | |
| ID16994A (id) | Unit proses | |
| FI972251A7 (fi) | Lastulevyjen valmistusmenetelmä | |
| DE69730605D1 (de) | Dragier-produkte und herstellungsverfahren | |
| ATE249436T1 (de) | Herstellungsverfahren | |
| DE69713155D1 (de) | Halbleiteranordnung und herstellungsverfahren | |
| FR2766920B1 (fr) | Micromonochromateur et procede de realisation de celui-ci |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1028752 Country of ref document: EP |